Benfluorex, once licensed in some countries to treat diabetes and hyperlipidemia but also used to reduce obesity, actually increased patients' risk of left heart valve regurgitation.
Reuters Health Information
via Medscape news
Reuters Health Information
via Medscape news
No comments:
Post a Comment